460
Views
53
CrossRef citations to date
0
Altmetric
Review

Nanodisks: hydrophobic drug delivery vehicles

, PhD
Pages 343-351 | Published online: 05 Mar 2008
 

Abstract

Members of the class of exchangeable apolipoproteins possess the unique capacity to transform phospholipid vesicle substrates into nanoscale disk-shaped bilayers. This reaction can proceed in the presence of exogenous hydrophobic biomolecules, resulting in the formation of novel transport vehicles termed nanodisks (NDs). The objective of this study is to describe the structural organization of NDs and evaluate the utility of these complexes as hydrophobic biomolecule transport vehicles. The topics presented focus on two distinct water insoluble drugs, amphotericin B (AMB) and all trans retinoic acid (ATRA). In vitro and in vivo studies reveal that AMB–ND display potent anti-fungal and anti-protozoal activity, while ATRA–ND show promise in the treatment of cancer. The versatility conferred by the presence of a polypeptide component provides opportunities for targeted delivery of ND to cells.

Acknowledgements

The author gratefully acknowledges the contributions of colleagues and associates who have facilitated research on drug delivery vehicles. These include Son Nguyen, Richard Titus, Keith Nelson, Trudy Forte, Amareshwar Singh, Leo Gordon, Katherine Redmond, Michael Oda, Jennifer Beckstead and Megan Tufteland.

Notes

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.